Saba Malak
Saba Malak’s career has spanned strategic consulting, public equity investments, and leadership and operation of startups. He has deep experience in healthcare and technology companies.
Most recently, Mr. Malak was Chief Executive Officer of Zahav Bioscience, a clinical stage oncology company established by a large family office to develop Cytimmune Sciences’ therapeutics assets.
David O’Reilly
David O’Reilly has over 25 years of experience as a consultant in the life sciences industry and in the founding, financing, scaling and partnering of innovative pharmaceutical and medical technology companies. He currently provides strategic advisory, product development and financing services to global life sciences companies, start-ups and investors.